Sara Munjampalli, MD
Sleep Medicine · Shreveport, LANPI 1437446341
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 48.4% of the total. Reporting peaked in 2024 at $9,220 and has fallen 68.1% since, to $2,938 in 2025. Among sleep medicine clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 267 payments — averaging $70.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$9K
- Inspire Medical Systems, Inc.$4K
- ZOLL Respicardia, Inc.$2K
- Harmony Biosciences LLC$1K
- Itamar Medical Inc$971
- Axsome Therapeutics, Inc.$731
- plus $706 from 10 others
What the payments were for
- Consulting fees$3502%
- Speaking & faculty fees$5,76431%
- Travel & lodging$3,95921%
- Food & beverage$8,43845%
- Education$3702%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 63 | $9,129 |
| Inspire Medical Systems, Inc. | 76 | $4,135 |
| ZOLL Respicardia, Inc. | 10 | $2,024 |
| Harmony Biosciences LLC | 62 | $1,184 |
| Itamar Medical Inc | 6 | $971 |
| Axsome Therapeutics, Inc. | 24 | $731 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $288 |
| Idorsia Pharmaceuticals US Inc | 8 | $167 |
| Amgen | 3 | $64 |
| Scilex Pharmaceuticals Inc. | 2 | $49 |
| AbbVie | 3 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$7,792
- remede System$1,732
- Inspire Upper Airway Stimulation System$1,493
- Inspire$725
- WatchPat$476
- WatchPATONE$420
- SUNOSI$241
- LUMRYZ$200
- XYREM$150
How this compares
$18,881 in reported general payments places this provider in the 90th percentile of 20 sleep medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| WakixPitolisant Hcl | 36 | $503,451 |
| SunosiSolriamfetol Hcl | 32 | $40,762 |
| Modafinil | 44 | $2,503 |
| Zolpidem Tartrate ErZolpidem Tartrate | 11 | $1,029 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 25 | $868 |
| Zolpidem Tartrate | 156 | $573 |
| Eszopiclone | 52 | $505 |
| Buspirone Hcl | 26 | $379 |
| Doxepin Hcl | 22 | $306 |
| Temazepam | 18 | $301 |
| Mirtazapine | 19 | $188 |
| Amitriptyline Hcl | 11 | $107 |
| Trazodone Hcl | 35 | $99 |
| Clonazepam | 36 | $93 |
| Ropinirole Hcl | 13 | $92 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $1,184 | $503,45136 claims |
| Axsome Therapeutics, Inc.Sunosi | $731 | $40,76232 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 20 sleep medicine providers in Louisiana.
Other sleep medicine in Shreveport
- Oleg ChernyshevShreveport$15K
- Brittany MonceauxShreveport$4K
- Naomi GhildiyalShreveport$3K
- Syeda MunirShreveport$344
- Megan SmalleyShreveport$265
- Mary Beth McGannShreveport$234
- Catherine OwensShreveport$130
- Matthew AbrahamLafayette$23K
- Joseph BordelonOpelousas$8K
- Dwayne HenryBaton Rouge$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.